301 related articles for article (PubMed ID: 37506096)
1. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
Meijboom R; York EN; Kampaite A; Harris MA; White N; Valdés Hernández MDC; Thrippleton MJ; MacDougall NJJ; Connick P; Hunt DPJ; Chandran S; Waldman AD;
PLoS One; 2023; 18(7):e0288967. PubMed ID: 37506096
[TBL] [Abstract][Full Text] [Related]
2. Quantitative T
Harper JG; York EN; Meijboom R; Kampaite A; Thrippleton MJ; Kearns PKA; Valdés Hernández MDC; Chandran S; Waldman AD;
Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
[TBL] [Abstract][Full Text] [Related]
3. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
4. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Dong X; Xu G; Wang J; Yin N; Meng N
Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
[TBL] [Abstract][Full Text] [Related]
5. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
6. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
York EN; Meijboom R; Thrippleton MJ; Bastin ME; Kampaite A; White N; Chandran S; Waldman AD;
Neuroimage Clin; 2022; 36():103228. PubMed ID: 36265199
[TBL] [Abstract][Full Text] [Related]
8. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
[TBL] [Abstract][Full Text] [Related]
9. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
10. Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis.
Pagani E; Storelli L; Pantano P; Petsas N; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
J Neurol; 2023 Jan; 270(1):446-459. PubMed ID: 36152049
[TBL] [Abstract][Full Text] [Related]
11. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
12. The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.
Bonacchi R; Meani A; Pagani E; Marchesi O; Filippi M; Rocca MA
J Neurol; 2022 Jul; 269(7):3841-3857. PubMed ID: 35230471
[TBL] [Abstract][Full Text] [Related]
13. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
14. Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates.
Rekik A; Aissi M; Rekik I; Mhiri M; Frih MA
Brain Behav; 2022 May; 12(5):e2573. PubMed ID: 35398999
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study.
Margoni M; Pagani E; Preziosa P; Gueye M; Azzimonti M; Rocca MA; Filippi M
J Neurol; 2023 Aug; 270(8):3839-3850. PubMed ID: 37093395
[TBL] [Abstract][Full Text] [Related]
17. Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study.
Bergsland N; Horakova D; Dwyer MG; Uher T; Vaneckova M; Tyblova M; Seidl Z; Krasensky J; Havrdova E; Zivadinov R
Neuroimage Clin; 2018; 17():444-451. PubMed ID: 29159057
[TBL] [Abstract][Full Text] [Related]
18. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
19. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
[TBL] [Abstract][Full Text] [Related]
20. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Filippi M;
Neurology; 2021 Mar; 96(11):e1561-e1573. PubMed ID: 33441452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
